Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2014 Dec 9;24(2):448–453. doi: 10.1158/1055-9965.EPI-14-1076

Table 2.

Association of race and risk of conventional adenomas and serrated polyps in people ≤ 50 and > 50 years of age

≤ 50 years > 50 years
Conventional Adenoma Black (n=21) White (n=390) RRa (95% CI) Black (n=172) White (n=2022) RRa (95% CI)
 Any 10 130 1.0 1.70c (0.99–2.92) 82 958 1.0 1.08 (0.92–1.27)
 Advanced Histologyb 4 19 1.0 5.52c (1.87–14.97) 22 228 1.0 1.25 (0.86–1.90)
 Any Advancedb 4 26 1.0 4.05c (1.43–11.46) 23 288 1.0 1.05 (0.71–1.56)
 Proximal 7 90 1.0 1.72 (0.85–3.49) 63 649 1.0 1.24d (1.00–1.53)
 Distal 6 56 1.0 1.93 (0.89–4.24) 49 583 1.0 1.08 (0.84–1.38)
Serrated Polyp
 Any 5 118 1.0 0.75 (0.34–1.62) 35 623 1.0 0.65d (0.49–0.87)
 Proximal 2 29 1.0 1.17 (0.28–4.89) 13 206 1.0 0.67 (0.40–1.16)
 Distal 4 101 1.0 0.69 (0.28–1.69) 27 518 1.0 0.61d (0.43–0.86)
a

RR for black race compared to white race adjusted for age, sex, study treatment assignment, and follow-up time

b

Advanced histology adenoma includes lesions with 25% or more villous histology; any advanced adenoma includes adenomas that have advanced histology, large size, high-grade dysplasia, and/or invasive cancer.

c

p-value for differences between younger blacks and whites for any conventional adenoma (p=0.06), advanced histology (p =0.002), and any advanced adenoma (p =0.008).

d

p-value for difference between older blacks and whites for any proximal conventional adenoma (p=0.05), serrated polyp (p=0.004) and distal serrated polyps (p =0.004).